We previously reported that CSNK1D, localized in the 17q25.3 genomic region, is frequently amplified in triple negative breast cancer, particularly in BRCA1 mutated breast cancer, and the increased copy number correlates with increased CSNK1D mRNA [4]. Here, CSNK1D is linked to triple-negative breast carcinoma.